Inhibition of cytokinesis by a lipid metabolite, psychosine.
about
Identification of a molecular target of psychosine and its role in globoid cell formation.Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.Neuroimmune mechanisms in Krabbe's diseasefumble encodes a pantothenate kinase homolog required for proper mitosis and meiosis in Drosophila melanogasterCharacterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced ResponsesLysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular ToxicityGloboid cell leukodystrophy (Krabbe's disease): update.Functional characterization of Aspergillus nidulans ypkA, a homologue of the mammalian kinase SGKSynthesis and properties of a photoactivatable analogue of psychosine (beta-Galactosylsphingosine).Psychosine-triggered endomitosis is modulated by membrane sphingolipids through regulation of phosphoinositide 4,5-bisphosphate production at the cleavage furrow.Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.Psychosine-induced alterations in peroxisomes of twitcher mouse liverThe role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe diseaseMMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathologyA microglial hypothesis of globoid cell leukodystrophy pathology.Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy.Making the cut: the chemical biology of cytokinesis.The cellular pathology of lysosomal diseases.Ceramide function in the brain: when a slight tilt is enough.Lysosomal storage diseases--the horizon expands.Endothelial cell dysfunction in globoid cell leukodystrophy.Krabbe's leukodystrophy: Approaches and models in vitro.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases.Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.C18:3-GM1a induces apoptosis in Neuro2a cells: enzymatic remodeling of fatty acyl chains of glycosphingolipids.Psychosine, cytokinesis, and orphan receptors. Unexpected connections.Palmitate impairs cytokinesis associated with RhoA inhibition.Axonopathy is a compounding factor in the pathogenesis of Krabbe disease.Glucosylceramide modulates membrane traffic along the endocytic pathway.Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride.An essential function of sphingolipids in yeast cell division.Reduced cerebral vascularization in experimental neuronopathic Gaucher disease.B cell lymphoma and myeloma in murine Gaucher's disease.
P2860
Q24680348-39E7D531-F44E-4CF2-BD01-863129867F2DQ27680741-94954AB2-D6A4-4C5E-8E10-ADF6DAAAE4C8Q28079115-CA515A82-61EF-44E7-B487-8D18D458DC5EQ28359866-A90194E9-1CEC-4C80-AEAD-E85820D2E445Q28548280-FC0CF7A3-1C0F-4FD8-A2D6-49001AF3FAF8Q28555118-FC331D9F-211E-4B48-9059-64F3F50E3842Q34542704-81413E61-8C5A-4F4F-B5D5-353BC5269D43Q34614412-2BEDE7B0-BA0E-45D6-8FC8-6F7AA6ED90A9Q36296773-1B9463A7-074F-45C7-A808-6FC3B0E72201Q37052732-00537C29-6154-4013-AE99-34C1DFF3DEA6Q37124501-80722AE8-0C4C-4105-AC4B-1023947663D2Q37125648-A7C4958D-5850-428E-B529-199EEBFFA762Q37171172-6FE78D8C-E4C1-42AE-BB43-773D5FCB8590Q37244151-A7A96E0F-657F-4BB8-BBE7-3488702341A7Q37265497-56F94BA8-A958-42D7-9B88-E67C9C88C99EQ37530795-B637CE8B-4D65-4C74-ACB3-B606C44250B1Q37656187-2226B680-FD17-4C5E-AAAC-8818DEC17FA6Q37944549-8B913276-196E-4E9D-B34A-30CE21BF320DQ38021345-62760238-C13D-4FE9-9578-797C1BF31BF5Q38128478-E1B0C830-F2EC-46E7-9DC7-5105FC6475B8Q38796127-6945CA3C-43F0-4902-9362-B8C4980721DDQ38820281-D7ABFC0D-3639-4E76-9F5A-11EEE6C90D00Q38957246-74523A56-4831-4E83-BDBF-3B1F3024D2C9Q39397868-6470CE93-D8D8-463A-9E49-F90818E9C278Q40286377-9E4B130F-9C4E-4B9E-A385-2FE146DFFCADQ40445807-1C0FE6C8-C1A7-42B3-987B-647662F03A93Q40811924-61DF0234-A8E1-4B41-9399-F59CFA4258CAQ42828503-4F380CBE-F234-4D49-B824-3B9DA09D82ADQ43118014-FF05235E-827C-49FC-85A1-5335E5D8D331Q44195483-0527577C-9734-4FE1-BA60-CA7A55EC1B04Q44272174-88A9600A-4BFA-4658-9F4B-D85661436B76Q44429382-6EF6BFB9-CBC0-4FA7-BA2F-13FC38D59C1AQ45838932-051D1C91-B210-4A6A-90C4-EAA1B35E02ADQ48032967-EF3FD9AD-EFC3-42BD-A508-5972C12C5C3DQ50899591-E3079B63-DCC7-461D-8FE5-32A37FC676D4
P2860
Inhibition of cytokinesis by a lipid metabolite, psychosine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Inhibition of cytokinesis by a lipid metabolite, psychosine.
@en
type
label
Inhibition of cytokinesis by a lipid metabolite, psychosine.
@en
prefLabel
Inhibition of cytokinesis by a lipid metabolite, psychosine.
@en
P2093
P2860
P356
P1476
Inhibition of cytokinesis by a lipid metabolite, psychosine.
@en
P2093
Kanazawa T
Kawasaki T
Kozutsumi Y
Nakamura S
Takematsu H
Yamamoto A
P2860
P304
P356
10.1083/JCB.149.4.943
P407
P577
2000-05-01T00:00:00Z